Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras GTPases are small, single-subunit guanosine-nucleotide-binding proteins that function as molecular switches in the cell. They cycle between an inactive GDP-bound state and an active GTP-bound state, regulating a wide array of cytoplasmic signaling pathways involved in gene expression, cell growth, survival, differentiation, and apoptosis. Mutations in RAS genes, especially those that impair intrinsic or GAP-stimulated GTP hydrolysis, lead to constitutive activation, acting as oncogenic drivers found in approximately 10–20% of human cancers.
Inhibition of Ras GTPase activity or downstream signaling pathways
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras GTPase (Ras).